Forte Biosciences (FBRX) Notes Payables (2016 - 2020)
Forte Biosciences (FBRX) has disclosed Notes Payables for 5 consecutive years, with $5.0 million as the latest value for Q1 2020.
- Quarterly Notes Payables rose 126.0% to $5.0 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Mar 2020, up 126.0% year-over-year, with the annual reading at $4.7 million for FY2019, N/A changed from the prior year.
- Notes Payables for Q1 2020 was $5.0 million at Forte Biosciences, up from $4.7 million in the prior quarter.
- The five-year high for Notes Payables was $27.8 million in Q3 2019, with the low at $2.2 million in Q1 2019.
- Average Notes Payables over 5 years is $7.9 million, with a median of $7.2 million recorded in 2016.
- The sharpest move saw Notes Payables crashed 69.39% in 2019, then skyrocketed 126.0% in 2020.
- Over 5 years, Notes Payables stood at $7.2 million in 2016, then changed by 0.0% to $7.2 million in 2017, then changed by 0.0% to $7.2 million in 2018, then crashed by 34.11% to $4.7 million in 2019, then grew by 5.0% to $5.0 million in 2020.
- According to Business Quant data, Notes Payables over the past three periods came in at $5.0 million, $4.7 million, and $27.8 million for Q1 2020, Q4 2019, and Q3 2019 respectively.